24 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18658989 | MEANS AND METHODS OF PREVENTING OR REVERSING AGING | EBBINGHAUS, BRIANA NOEL | 1632 | Non-Final OA | May 09, 2024 |
| 18486731 | GENE THERAPY FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS | LEONARD, ARTHUR S | 1631 | Non-Final OA | Oct 13, 2023 |
| 18040345 | REDUCTION OF COVID-19 COAGULOPATHY AND OTHER INFLAMMATION-ASSOCIATED COAGULOPATHIES BY ADMINISTRATION OF FIBROBLASTS | MIANO, JOSEPH PAUL | 1631 | Non-Final OA | Feb 02, 2023 |
| 17999583 | FIBROBLAST THERAPY FOR PREVENTION AND REVERSION OF ANEURYSMS | FOX, ALLISON M | 1633 | Non-Final OA | Nov 22, 2022 |
| 17999588 | AUGMENTATION OF FIBROBLAST CELL THERAPY EFFICACY BY MICROBIOME MANIPULATION | BABIC, CHRISTOPHER M | 1633 | Non-Final OA | Nov 22, 2022 |
| 17998380 | TREATMENT OF OVARIAN FAILURE USING REGENERATIVE CELLS | SCHUBERG, LAURA J | 1631 | Non-Final OA | Nov 10, 2022 |
| 17998183 | FIBROBLAST BASED THERAPY FOR TREATMENT OF PARKINSON'S DISEASE | BERTOGLIO, VALARIE E | 1632 | Non-Final OA | Nov 08, 2022 |
| 17997674 | REDUCTION OF CYTOKINE STORM AND PATHOLOGICAL INFLAMMATION INCLUDING CAUSED BY CORONAVIRUS USING SPHAGNUM AND EXTRACTS THEREOF | PALENIK, JEFFREY T | 1615 | Non-Final OA | Nov 01, 2022 |
| 17907115 | METHODS AND COMPOSITIONS FOR ALLERGY AND ASTHMA TREATMENT USING FIBROBLASTS | SCHUBERG, LAURA J | 1631 | Final Rejection | Sep 23, 2022 |
| 17905197 | GENERATION OF AUTOIMMUNE INHIBITORY T CELLS BY FIBROBLAST MEDIATED EDUCATION | MIANO, JOSEPH PAUL | 1631 | Non-Final OA | Aug 29, 2022 |
| 17755834 | FIBROBLAST THERAPY FOR INFLAMMATORY BOWEL DISEASE | MOSS, NATALIE M | 1653 | Final Rejection | May 10, 2022 |
| 17755275 | FIBROBLAST-DERIVED UNIVERSAL IMMUNOLOGICAL COMPOSITION | BARRON, SEAN C | 1653 | Final Rejection | Apr 26, 2022 |
| 17753487 | TREATMENT OF TRAUMATIC ENCEPHALOPATHY BY FIBROBLASTS AND THERAPEUTIC ADJUVANTS | ROBINSON, MIKHAIL O'DONNEL | 1627 | Non-Final OA | Mar 04, 2022 |
| 17596889 | TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED NEUROINFLAMMATION USING FIBROBLASTS AND DERIVATIVES THEREOF | BARRON, SEAN C | 1653 | Non-Final OA | Dec 20, 2021 |
| 17595112 | FIBROBLAST GENERATED PATIENT-SPECIFIC VACCINES | CHASE, CAROL ANN | 1646 | Non-Final OA | Nov 09, 2021 |
| 17594730 | ENHANCEMENT OF FIBROBLAST THERAPEUTIC ACTIVITY BY T CELL MODULATION | HOWARD, ZACHARY C | 1674 | Non-Final OA | Oct 27, 2021 |
| 17310051 | FIBROBLASTS AND MICROVESICLES THEREOF FOR REDUCTION OF TOXICITY ASSOCIATED WITH CANCER IMMUNOTHERAPY | DHAR, MATASHA | 1632 | Non-Final OA | Jul 13, 2021 |
| 17310007 | FIBROBLAST REGENERATIVE CELLS | TRAN, KHOA NHAT | 1632 | Non-Final OA | Jul 09, 2021 |
| 17309649 | THERAPEUTIC USES OF GENE EDITED FIBROBLASTS | TRAN, KHOA NHAT | 1632 | Non-Final OA | Jun 11, 2021 |
| 17309207 | REGENERATIVE ABSCOPAL EFFECTS | RIGA, MICHAEL ANGELO | 1634 | Non-Final OA | May 26, 2021 |
| 17309178 | TREATMENT OF CEREBRAL HYPOXIA INCLUDING STROKE, CHRONIC TRAUMATIC ENCEPHALOPATHY, AND TRAUMATIC BRAIN INJURY | XU, QING | 1656 | Non-Final OA | May 03, 2021 |
| 17271529 | CHIMERIC ANTIGEN RECEPTOR FIBROBLAST CELLS FOR TREATMENT OF CANCER | LEVIN, JOEL D | 1633 | Non-Final OA | Feb 25, 2021 |
| 17251587 | USE OF FIBROBLASTS AND/OR MODIFIED FIBROBLASTS FOR THREE DIMENSIONAL TISSUE PRINTING | REGLAS, GILLIAN CHELSEA | 1632 | Non-Final OA | Dec 11, 2020 |
| 17052859 | PAIN-REDUCING EFFECTS OF FIBROBLASTS AND TREATMENT OF PAIN | TRAN, KHOA NHAT | 1632 | Final Rejection | Nov 04, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial